One-Year Study Demonstrates Vision-Sciences' EndoSheath Technology Protects Against Bacterial Contamination of Bronchoscopes
October 22, 2013 08:00 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that the detailed findings of a twelve-month evaluation of its EndoSheath® technology in...
Evaluation at UK Deployed Field Hospital Demonstrates Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy
September 09, 2013 08:40 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reports First Quarter 2014 Financial Results
August 12, 2013 16:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for the first quarter of fiscal 2014, ended June 30, 2013. Highlights...
Vision-Sciences to Discuss First Quarter of Fiscal 2014 Results on August 13 Conference Call
August 01, 2013 16:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
May 13, 2013 17:01 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 13, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013
April 29, 2013 17:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results
April 23, 2013 17:18 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System
March 18, 2013 16:05 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors
March 12, 2013 16:38 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference
March 06, 2013 16:15 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...